[
  {
    "ts": null,
    "headline": "This 3 Stocks Portfolio Provides Monthly Income",
    "summary": "Who doesn't like payday? Investors can structure a portfolio that provides monthly income with this combination of three stocks.",
    "url": "https://finnhub.io/api/news?id=9f464fcd11abb39ade332acc5f0da40acc9679ae2ac6d86902713062dd40c225",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761091020,
      "headline": "This 3 Stocks Portfolio Provides Monthly Income",
      "id": 137187751,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Who doesn't like payday? Investors can structure a portfolio that provides monthly income with this combination of three stocks.",
      "url": "https://finnhub.io/api/news?id=9f464fcd11abb39ade332acc5f0da40acc9679ae2ac6d86902713062dd40c225"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Reports for Apple, Meta Platforms & JPMorgan",
    "summary": "Apple's Services surge, Meta's AI push, and JPMorgan's strong capital markets results headline today's top stock research picks.",
    "url": "https://finnhub.io/api/news?id=36d519b7618b1563c8c3f153289e5a138c8a2f32182db9d17d878fb14e7bc546",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761077820,
      "headline": "Top Stock Reports for Apple, Meta Platforms & JPMorgan",
      "id": 137187679,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Apple's Services surge, Meta's AI push, and JPMorgan's strong capital markets results headline today's top stock research picks.",
      "url": "https://finnhub.io/api/news?id=36d519b7618b1563c8c3f153289e5a138c8a2f32182db9d17d878fb14e7bc546"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie's Rinvoq Beats Humira in Key Arthritis Trial",
    "summary": "New data show stronger remission rates as AbbVie shifts beyond Humira.",
    "url": "https://finnhub.io/api/news?id=4cb621519ef8b2b7b3eae361da1bfac12e716767a62e65cb016b773e5c585af6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761062852,
      "headline": "AbbVie's Rinvoq Beats Humira in Key Arthritis Trial",
      "id": 137180569,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "New data show stronger remission rates as AbbVie shifts beyond Humira.",
      "url": "https://finnhub.io/api/news?id=4cb621519ef8b2b7b3eae361da1bfac12e716767a62e65cb016b773e5c585af6"
    }
  },
  {
    "ts": null,
    "headline": "The Confidence Project by BOTOX速 Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients",
    "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced this year's grant recipients of The Confidence Project: Empowering Women Entrepreneurs. After completing a 12-week \"Boostcamp\" and leveraging their newfound skills to pitch their business to a panel of aesthetic entrepreneurs and Allergan Aesthetics executives, 20 entrepreneurs were selected. Each entrepreneur receives a $20,000 grant funded by BOTOX速 Cosmetic.",
    "url": "https://finnhub.io/api/news?id=71da9c5e075304d4ba1a5ae818b67fcea2df7c0d70a0a0fc6200accde129b31a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761048000,
      "headline": "The Confidence Project by BOTOX速 Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients",
      "id": 137177947,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced this year's grant recipients of The Confidence Project: Empowering Women Entrepreneurs. After completing a 12-week \"Boostcamp\" and leveraging their newfound skills to pitch their business to a panel of aesthetic entrepreneurs and Allergan Aesthetics executives, 20 entrepreneurs were selected. Each entrepreneur receives a $20,000 grant funded by BOTOX速 Cosmetic.",
      "url": "https://finnhub.io/api/news?id=71da9c5e075304d4ba1a5ae818b67fcea2df7c0d70a0a0fc6200accde129b31a"
    }
  },
  {
    "ts": null,
    "headline": "Uncovering 3 Stocks Including Palo Alto Networks That May Be Trading Below Intrinsic Value Estimates",
    "summary": "As the U.S. stock market begins the week on a high note, buoyed by gains across major indices and ongoing developments in trade and inflation data, investors are keenly observing opportunities amid economic uncertainties like the prolonged government shutdown. In this environment, identifying stocks that may be trading below their intrinsic value can offer potential for growth, making it crucial to consider factors such as financial health and market position when evaluating investment...",
    "url": "https://finnhub.io/api/news?id=fa6d70a7954137681b61e9908f06a3e571d7478c850e3f89d8b4cfb0a0c960a9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761046681,
      "headline": "Uncovering 3 Stocks Including Palo Alto Networks That May Be Trading Below Intrinsic Value Estimates",
      "id": 137177948,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "As the U.S. stock market begins the week on a high note, buoyed by gains across major indices and ongoing developments in trade and inflation data, investors are keenly observing opportunities amid economic uncertainties like the prolonged government shutdown. In this environment, identifying stocks that may be trading below their intrinsic value can offer potential for growth, making it crucial to consider factors such as financial health and market position when evaluating investment...",
      "url": "https://finnhub.io/api/news?id=fa6d70a7954137681b61e9908f06a3e571d7478c850e3f89d8b4cfb0a0c960a9"
    }
  },
  {
    "ts": null,
    "headline": "SCHD: Bears Are Theoretically Right, But Here Is Why I Am Buying Now",
    "summary": "Schwab U.S. Dividend Equity ETF stands out for its attractive 3.9% yield and strong dividend growth. Click here to read why SCHD ETF is a Buy.",
    "url": "https://finnhub.io/api/news?id=b6b89ce743da13153274d8234a053fd41f645f0d8f1603ab9bf0fe152a7048ef",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761038100,
      "headline": "SCHD: Bears Are Theoretically Right, But Here Is Why I Am Buying Now",
      "id": 137177455,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1277179014/image_1277179014.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Schwab U.S. Dividend Equity ETF stands out for its attractive 3.9% yield and strong dividend growth. Click here to read why SCHD ETF is a Buy.",
      "url": "https://finnhub.io/api/news?id=b6b89ce743da13153274d8234a053fd41f645f0d8f1603ab9bf0fe152a7048ef"
    }
  }
]